Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection-Reference-Cited by-同舟云学术

Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection

Published:2015-06 Issue:23 Volume:94 Page:e879
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Xu Ya-Ping,Li Bo,Xu Xiao-Ling,Mao Wei-Min

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference26 articles.

1. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.;Molina;Mayo Clin Proc,2008

2. The value of mediastinoscopy in assessing operability in carcinoma of the lung.;Gibbons;Br J Dis Chest,1972

3. Relationship of cell type and lymph node metastasis to survival after resection of bronchial carcinoma.;Shields;Ann Thorac Surg,1975

4. Long-term survival after resection for bronchogenic carcinoma.;Paulson;Ann Surg,1976

5. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22NVALT 2EORTC 08012 multicentre randomised trial and update of systematic review.;Gilligan;Lancet,2007

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologic Response and Survival after Neoadjuvant Chemotherapy with Bevacizumab Followed by Surgery for Clinical Stage II/IIIA Nonsquamous Non-Small-Cell Lung Cancer: Results from a Phase II Feasibility Study (NAVAL);Cancers;2024-06-27

2. Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials;Frontiers in Immunology;2024-04-05

3. 10-hydroxycamptothecin-loaded starch-based microcapsules with the stepwise responsive release strategy for targeted controlled release;International Journal of Biological Macromolecules;2023-12

4. Immunotherapy for early-stage non-small cell lung cancer: A system review;Journal of Cancer Research and Therapeutics;2023-08

5. The prognosis of clinical stage IIIa non‐small cell lung cancer in Taiwan;Cancer Medicine;2023-07-26